Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry

Biomarkers in Medicine

Volumn 5, Issue 4, 2011, Pages 451-460

  Kondo, Yasuyuki ^a   Nishiumi, Shin ^a   Shinohara, Masakazu ^a   Hatano, Naoya ^a   Ikeda, Atsuki ^a   Yoshie, Tomoo ^a   Kobayashi, Takashi ^a   Shiomi, Yuuki ^a   Irino, Yasuhiro ^a   Takenawa, Tadaomi ^a   Azuma, Takeshi ^a   Yoshida, Masaru ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

biomarker; colorectal cancer; gas chromatography mass spectrometry; metabolomics; serum fatty acid

Indexed keywords

FATTY ACID; VERY LONG CHAIN FATTY ACID;

ADULT; AGED; ARTICLE; BODY MASS; CANCER LOCALIZATION; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CECUM; CLINICAL ARTICLE; COLON ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DESCENDING COLON; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; RECTUM; SIGMOID; TRANSVERSE COLON;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; DISCRIMINANT ANALYSIS; EARLY DIAGNOSIS; FATTY ACIDS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 80052041295     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.11.41     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer Clin. 59(4), 225-249 (2009).
2. Matsuda T, Marugame T, Kamo KI, Katanoda K, Ajiki W, Sobue T; The Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2004: based on data from 14 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J. Clin. Oncol. 40(12), 1192-1200 (2010).
3. Yang YJ, Lee SH, Hong SJ, Chung BC. Comparison of fatty acid profles in the serum of patients with prostate cancer and benign prostatic hyperplasia. Clin. Biochem. 32(6), 405-409 (1999). (Pubitemid 29536171)
4. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140(1), 49-61 (2010).
5. Kolonel LN, Nomura AM, Cooney RV. Dietary fat and prostate cancer: current status. J. Natl Cancer Inst. 91(5), 414-428 (1999). (Pubitemid 29128277)
6. Connolly JM, Coleman M, Rose DP. Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr. Cancer 29(2), 114-119 (1997). (Pubitemid 28009831)
7. Wang Y, Corr JG, Thaler HT et al. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J. Natl Cancer Inst. 87(19), 1456-1462 (1995).
8. Qiu Y, Cai G, Su M et al. Serum metabolite profling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J. Proteome Res. 8(10), 4844-4850 (2009).
9. 1H magnetic resonance spectroscopy. Metabolomics 5, 292-301 (2009).
10. Kabuto H, Amakawa M, Mankura M, Yamanushi T T, Mori A. Decosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum. Neurochem. Res. 34(7), 1299-1303 (2009).
11. Tsukamoto S, Fujiwara K, Ikeguchi M. Fatty acids bound to recombinant tear lipocalin and their role in structural stabilization. J. Biochem. 146(3), 343-350 (2009).
12. Simopoulos AP. Genetic variants in the metabolism of co-6 and co-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Exp. Biol. Med. (Maywood) 235(7), 785-795 (2010).
13. Hull MA, Ko SC, Hawcroft G et al. Prostglandin EP receptor: targets for treatment and prevention of colorectal cancer? Mol. Cancer Ther. 3(8), 1031-1039 (2004). (Pubitemid 39199598)
14. Massoumi R, Sjölander A. The role of leukotriene receptor signaling in infammation and cancer. Scientifc World J. 7, 1413-1421 (2007). (Pubitemid 47435432)
15. Reddy BS. co-3 fatty acids in colorectal cancer prevention. Int. J. Cancer 112(1), 1-7 (2004). (Pubitemid 39249485)
16. Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2000: estimates based on data from 11 population-based cancer registries. Jpn Clin. Oncol. 36(10), 668-675 (2006). (Pubitemid 44697563)
17. Koki AT, Masferrer JL. Celecoxib: a specifc COX-2 inhibitor with anticancer properties. Cancer Control 9(2 Suppl.), 28-35 (2002). (Pubitemid 34457338)
18. Orita H, Coulter J, Tully E et al. High levels of fatty acid synthase expression in esophageal cancers represent a potential target for therapy. Cancer Biol. Ther. 10(6), 549-554 (2010).
19. Walter K, Hong SM, Nyhan S et al. Serum fatty acid synthase as a marker of pancreatic neoplasia. Cancer Epidemiol. Biomarkers Prev. 18(9), 2380-2385 (2009).
20. Ikeda M, Kanao Y, Yamanaka M et al. Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases involved in very long-chain fatty acid synthesis. FEBS Lett. 582(16), 2435-2440 (2008).
21. Kihara A, Sakuraba H, Ikeda M, Denpoh A, Igarashi Y. Membrane topology and essential amino acid residues of Phs1, a 3-hydroxyacyl-CoA dehydratase involved in very long-chain fatty acid elongation. J. Biol. Chem. 283(17), 11199-11209 (2008).
22. Tamura K, Makino A, Hullin-Matsuda F et al. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism. Cancer Res. 69(20), 8133-8140 (2009).
23. Ritchie SA, Ahiahonu PW, Jayasinghe D et al. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 8, 13 (2010).
24. Tan B, Liang Y, Yi L et al. Identifcation of free fatty acids profling of Type 2 diabetes mellitus and exploring possible biomarkers by GC-MS coupled with chemometrics. Metabolomics 6, 219-228 (2010).
25. Nishiumi S, Shinohara M, Ikeda A et al. Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics 6, 518-528 (2010).
26. Bensaad K, Tsuruta A, Selak MA et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126(1), 107-120 (2006). (Pubitemid 44040989)
27. Matoba S, Kang JG, Patino WD et al. p53 regulates mitochondrial respiration. Science 312(5780), 1650-1653 (2006). (Pubitemid 43902663)